Quantinno Capital Management LP boosted its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) by 200.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,612 shares of the medical instruments supplier’s stock after acquiring an additional 11,747 shares during the quarter. Quantinno Capital Management LP’s holdings in Merit Medical Systems were worth $1,214,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of the business. Los Angeles Capital Management LLC purchased a new stake in shares of Merit Medical Systems in the fourth quarter worth approximately $25,000. Torren Management LLC acquired a new stake in shares of Merit Medical Systems during the fourth quarter worth approximately $38,000. Covestor Ltd grew its position in Merit Medical Systems by 252.6% during the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 336 shares in the last quarter. Danske Bank A S acquired a new position in Merit Medical Systems in the 3rd quarter valued at approximately $42,000. Finally, Quarry LP increased its stake in Merit Medical Systems by 185.9% in the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock valued at $44,000 after buying an additional 342 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on MMSI shares. Needham & Company LLC increased their target price on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. BTIG Research restated a “buy” rating and set a $105.00 price target on shares of Merit Medical Systems in a report on Tuesday. JPMorgan Chase & Co. upped their price target on shares of Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Piper Sandler increased their price objective on Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Finally, Wells Fargo & Company lifted their price objective on Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $100.00.
Merit Medical Systems Trading Up 0.3%
NASDAQ:MMSI opened at $90.76 on Friday. The stock’s 50 day moving average price is $75.05 and its 200 day moving average price is $72.25. Merit Medical Systems, Inc. has a 52 week low of $59.74 and a 52 week high of $94.75. The company has a market capitalization of $5.42 billion, a P/E ratio of 37.50, a P/E/G ratio of 2.28 and a beta of 0.49. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20.
Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.23. The firm had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, research analysts forecast that Merit Medical Systems, Inc. will post 3.81 EPS for the current fiscal year.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.
Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.
Featured Articles
- Five stocks we like better than Merit Medical Systems
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report).
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
